Atlas Trials

LHA510 Proof-of-Concept Study as a Maintenance Therapy for Patients With Wet Age-Related Macular Degeneration

Clinical trial NCT02355028 · COMPLETED

Trial details

NCT number
NCT02355028
Sponsor
Alcon, a Novartis Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Exudative Age-Related Macular Degeneration
Start date
2015-03-03
Primary completion
2016-09-15
Enrollment
136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.